Cargando…

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

(a) Summary for SGLT2i‐induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i‐induced changes in the medium CXCL1 level (each n = 4). (c) SGLT2i‐induced changes in the medium CXCL8 level (each n = 4). (d) SGLT2i‐induced changes in the medium CXCL10 level (each n = 4), (e)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakano, Dan, Kawaguchi, Takumi, Tsutsumi, Tsubasa, Hayakawa, Masako, Yoshio, Sachiyo, Koga, Hironori, Torimura, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021706/ https://www.ncbi.nlm.nih.gov/pubmed/35475201 http://dx.doi.org/10.1002/jgh3.12730

Ejemplares similares

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)
por: Nakano, Dan, et al.
Publicado: (2020)

Hepatic expression of sodium–glucose cotransporter 2 (SGLT2) in patients with chronic liver disease
por: Nakano, Dan, et al.
Publicado: (2022)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma
por: Tsuchihashi, Jin, et al.
Publicado: (2021)

Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
por: Takamura, Saori, et al.
Publicado: (2022)

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
por: Shimose, Shigeo, et al.
Publicado: (2021)

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
por: Hashida, Ryuki, et al.
Publicado: (2021)

Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma
por: Kawaguchi, Takumi, et al.
Publicado: (2020)

Effects of isomaltulose on insulin resistance and metabolites in patients with non-alcoholic fatty liver disease: A metabolomic analysis
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma
por: Shimose, Shigeo, et al.
Publicado: (2020)

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report
por: Hashida, Ryuki, et al.
Publicado: (2023)

Effects of In-Hospital Physical Therapy on Activities of Daily Living in Patients with Hepatocellular Carcinoma
por: Narao, Hayato, et al.
Publicado: (2020)

Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then
por: Kawaguchi, Takumi, et al.
Publicado: (2020)

Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis
por: Shirono, Tomotake, et al.
Publicado: (2021)

Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching
por: Shimose, Shigeo, et al.
Publicado: (2023)

Decrease in Dengue virus-2 infection and reduction of cytokine/chemokine production by Uncaria guianensis in human hepatocyte cell line Huh-7
por: Mello, Cíntia da Silva, et al.
Publicado: (2017)

Prevalence and profiles of ramucirumab-associated severe ascites in patients with hepatocellular carcinoma
por: Kamachi, Naoki, et al.
Publicado: (2021)

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
por: Iwamoto, Hideki, et al.
Publicado: (2022)

Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines
por: Louisa, Melva, et al.
Publicado: (2016)

Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line
por: Hashimoto, Osamu, et al.
Publicado: (2006)

The Inter-Organ Crosstalk Reveals an Inevitable Link between MAFLD and Extrahepatic Diseases
por: Tsutsumi, Tsubasa, et al.
Publicado: (2023)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B
por: Sano, Tomoya, et al.
Publicado: (2021)

Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
por: Shimose, Shigeo, et al.
Publicado: (2020)

Lenvatinib prolongs the progression-free survival time of patients with intermediate-stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis
por: Shimose, Shigeo, et al.
Publicado: (2020)

Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study
por: Shimose, Shigeo, et al.
Publicado: (2020)

Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
por: Shimose, Shigeo, et al.
Publicado: (2021)

MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men
por: Tsutsumi, Tsubasa, et al.
Publicado: (2022)

Matrix Metalloproteinase 2 Knockdown Suppresses the Proliferation of HepG2 and Huh7 Cells and Enhances the Cisplatin Effect
por: Liu, Jiangwei, et al.
Publicado: (2019)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
por: Koga, Hironori, et al.
Publicado: (2023)

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection
por: Sumie, Shuji, et al.
Publicado: (2011)

Molecular underpinnings of ssDNA specificity by Rep HUH-endonucleases and implications for HUH-tag multiplexing and engineering
por: Tompkins, Kassidy J, et al.
Publicado: (2021)

SLC6A8 Knockdown Suppresses the Invasion and Migration of Human Hepatocellular Carcinoma Huh-7 and Hep3B Cells
por: Yuan, Lu, et al.
Publicado: (2020)

Effect of Recombinant Human Erythroferrone Protein on Hepcidin Gene (Hamp1) Expression in HepG2 and HuH7 Cells
por: Than, Min Min, et al.
Publicado: (2021)

Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma
por: Schicht, Gerda, et al.
Publicado: (2022)

Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis
por: Arinaga-Hino, Teruko, et al.
Publicado: (2022)

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis
por: Nakano, Masahito, et al.
Publicado: (2020)

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound
por: Kamachi, Naoki, et al.
Publicado: (2021)

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma
por: Okamura, Shusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ia5egiq7th1mj9n4dvcg2o33i3